Subscribe to stay informed!
Chesterbrook-based Aclaris Therapeutics has parted ways with its CEO and has started a strategic review after the recent setbacks with two of its new…
A joint research project over the past year has impressed dermatology-focused Aclaris Therapeutics enough to buy out St. Louis startup Confluence Life Sciences.
The…
Before we send you to this site, please subscribe to our daily newsletter.